Is Switzerland Still a Lucrative Place for Manufacturers of Drug Substances to Produce Their Products?
Pharmaceutical manufacturers are coming under increasing pricing pressure as a result of healthcare reforms and are therefore looking to low wage countries in the Far East. Often, the outcome is a process that is not fully mature in economic terms. Contract synthesis manufacturers, such as...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | deu |
| Published: |
Swiss Chemical Society
2005-01-01
|
| Series: | CHIMIA |
| Subjects: | |
| Online Access: | https://chimia.ch/chimia/article/view/3939 |
| Summary: | Pharmaceutical manufacturers are coming under increasing pricing pressure as a result of healthcare reforms and are therefore looking to low wage countries in the Far East. Often, the outcome is a process that is not fully mature in economic terms. Contract synthesis manufacturers,
such as Siegfried, offer assistance here with its comprehensive pharmaceutical know-how in order to establish efficient and low-cost processes at an early stage. Siegfried's strengths lie in its many years experience in the pharmaceutical industry and in the network of contacts it has built
up over the years with technical and material suppliers. Therefore, as far as Switzerland as a location for manufacturing is concerned, Siegfried looks to the future with confidence.
|
|---|---|
| ISSN: | 0009-4293 2673-2424 |